Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Genetic Variation Underpinning ADHD Risk in a Caribbean Community.

Puentes-Rozo PJ, Acosta-López JE, Cervantes-Henríquez ML, Martínez-Banfi ML, Mejia-Segura E, Sánchez-Rojas M, Anaya-Romero ME, Acosta-Hoyos A, García-Llinás GA, Mastronardi CA, Pineda DA, Castellanos FX, Arcos-Burgos M, Vélez JI.

Cells. 2019 Aug 16;8(8). pii: E907. doi: 10.3390/cells8080907.

2.

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review.

Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA.

Diagnostics (Basel). 2019 Aug 7;9(3). pii: E91. doi: 10.3390/diagnostics9030091. Review.

3.

Uveitis and Multiple Sclerosis: Potential Common Causal Mutations.

de-la-Torre A, Silva-Aldana CT, Muñoz-Ortiz J, Piñeros-Hernández LB, Otero O, Domínguez A, Faciolince LA, Arcos-Holzinger M, Mastronardi C, Contreras-Bravo NC, Restrepo CM, Arcos-Burgos M.

Mol Neurobiol. 2019 Jun 3. doi: 10.1007/s12035-019-1630-2. [Epub ahead of print]

PMID:
31161422
4.

Congenital Leptin Deficiency and Leptin Gene Missense Mutation Found in Two Colombian Sisters with Severe Obesity.

Yupanqui-Lozno H, Bastarrachea RA, Yupanqui-Velazco ME, Alvarez-Jaramillo M, Medina-Méndez E, Giraldo-Peña AP, Arias-Serrano A, Torres-Forero C, Garcia-Ordoñez AM, Mastronardi CA, Restrepo CM, Rodriguez-Ayala E, Nava-Gonzalez EJ, Arcos-Burgos M, Kent JW Jr, Cole SA, Licinio J, Celis-Regalado LG.

Genes (Basel). 2019 May 7;10(5). pii: E342. doi: 10.3390/genes10050342.

5.

Neural Plasticity during Aging.

Arcos-Burgos M, Lopera F, Sepulveda-Falla D, Mastronardi C.

Neural Plast. 2019 Mar 26;2019:6042132. doi: 10.1155/2019/6042132. eCollection 2019. No abstract available.

6.

Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.

Vallejo-Diez S, Fleischer A, Martín-Fernández JM, Sánchez-Gilabert A, Castresana M, Aguillón D, Villegas A, Mastronardi CA, Espinosa LG, Arcos-Burgos M, Del Pozo Á, Herrán E, Gainza E, Isaza-Ruget M, Lopera F, Bachiller D.

Stem Cell Res. 2019 May;37:101440. doi: 10.1016/j.scr.2019.101440. Epub 2019 Apr 15.

7.

ADGRL3 (LPHN3) variants predict substance use disorder.

Arcos-Burgos M, Vélez JI, Martinez AF, Ribasés M, Ramos-Quiroga JA, Sánchez-Mora C, Richarte V, Roncero C, Cormand B, Fernández-Castillo N, Casas M, Lopera F, Pineda DA, Palacio JD, Acosta-López JE, Cervantes-Henriquez ML, Sánchez-Rojas MG, Puentes-Rozo PJ, Molina BSG; MTA Cooperative Group, Boden MT, Wallis D, Lidbury B, Newman S, Easteal S, Swanson J, Patel H, Volkow N, Acosta MT, Castellanos FX, de Leon J, Mastronardi CA, Muenke M.

Transl Psychiatry. 2019 Jan 29;9(1):42. doi: 10.1038/s41398-019-0396-7.

8.

Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer's Disease.

Vélez JI, Lopera F, Creagh PK, Piñeros LB, Das D, Cervantes-Henríquez ML, Acosta-López JE, Isaza-Ruget MA, Espinosa LG, Easteal S, Quintero GA, Silva CT, Mastronardi CA, Arcos-Burgos M.

Mol Neurobiol. 2019 May;56(5):3235-3243. doi: 10.1007/s12035-018-1298-z. Epub 2018 Aug 15.

9.

Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder.

Yu C, Arcos-Burgos M, Baune BT, Arolt V, Dannlowski U, Wong ML, Licinio J.

Transl Psychiatry. 2018 Mar 27;8(1):70. doi: 10.1038/s41398-018-0117-7.

10.

Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies.

da Fonseca ACP, Mastronardi C, Johar A, Arcos-Burgos M, Paz-Filho G.

J Diabetes Complications. 2017 Oct;31(10):1549-1561. doi: 10.1016/j.jdiacomp.2017.04.026. Epub 2017 Jun 16. Review.

11.

Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression.

Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, Abikoff HB, Stehli A, Owens EB, Mitchell JT, Nichols Q, Howard A, Greenhill LL, Hoza B, Newcorn JH, Jensen PS, Vitiello B, Wigal T, Epstein JN, Tamm L, Lakes KD, Waxmonsky J, Lerner M, Etcovitch J, Murray DW, Muenke M, Acosta MT, Arcos-Burgos M, Pelham WE, Kraemer HC; MTA Cooperative Group.

J Child Psychol Psychiatry. 2017 Jun;58(6):663-678. doi: 10.1111/jcpp.12684. Epub 2017 Mar 10.

12.

Reproductive success is predicted by social dynamics and kinship in managed animal populations.

Newman SJ, Eyre S, Kimble CH, Arcos-Burgos M, Hogg C, Easteal S.

F1000Res. 2016 May 11;5:870. eCollection 2016.

13.

Distinctive adaptive response to repeated exposure to hydrogen peroxide associated with upregulation of DNA repair genes and cell cycle arrest.

Santa-Gonzalez GA, Gomez-Molina A, Arcos-Burgos M, Meyer JN, Camargo M.

Redox Biol. 2016 Oct;9:124-133. doi: 10.1016/j.redox.2016.07.004. Epub 2016 Jul 21.

14.

An Ultraconserved Brain-Specific Enhancer Within ADGRL3 (LPHN3) Underpins Attention-Deficit/Hyperactivity Disorder Susceptibility.

Martinez AF, Abe Y, Hong S, Molyneux K, Yarnell D, Löhr H, Driever W, Acosta MT, Arcos-Burgos M, Muenke M.

Biol Psychiatry. 2016 Dec 15;80(12):943-954. doi: 10.1016/j.biopsych.2016.06.026. Epub 2016 Jul 14.

15.

ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study.

Acosta MT, Swanson J, Stehli A, Molina BS; MTA Team, Martinez AF, Arcos-Burgos M, Muenke M.

Mol Genet Genomic Med. 2016 Jul 18;4(5):540-7. doi: 10.1002/mgg3.230. eCollection 2016 Sep.

16.

Mutations modifying sporadic Alzheimer's disease age of onset.

Vélez JI, Lopera F, Patel HR, Johar AS, Cai Y, Rivera D, Tobón C, Villegas A, Sepulveda-Falla D, Lehmann SG, Easteal S, Mastronardi CA, Arcos-Burgos M.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1116-1130. doi: 10.1002/ajmg.b.32493. Epub 2016 Aug 30.

PMID:
27573710
17.

Retrospective assessment of childhood ADHD symptoms for diagnosis in adults: validity of a short 8-item version of the Wender-Utah Rating Scale.

Das D, Vélez JI, Acosta MT, Muenke M, Arcos-Burgos M, Easteal S.

Atten Defic Hyperact Disord. 2016 Dec;8(4):215-223. doi: 10.1007/s12402-016-0202-9. Epub 2016 Aug 10.

PMID:
27510231
18.

Polyautoimmunity in Sjögren Syndrome.

Anaya JM, Rojas-Villarraga A, Mantilla RD, Arcos-Burgos M, Sarmiento-Monroy JC.

Rheum Dis Clin North Am. 2016 Aug;42(3):457-72. doi: 10.1016/j.rdc.2016.03.005. Epub 2016 Jun 21. Review.

PMID:
27431348
19.

Role of the IL-1 Pathway in Dopaminergic Neurodegeneration and Decreased Voluntary Movement.

Stojakovic A, Paz-Filho G, Arcos-Burgos M, Licinio J, Wong ML, Mastronardi CA.

Mol Neurobiol. 2017 Aug;54(6):4486-4495. doi: 10.1007/s12035-016-9988-x. Epub 2016 Jun 29.

20.

Definition of mutations in polyautoimmunity.

Johar A, Sarmiento-Monroy JC, Rojas-Villarraga A, Silva-Lara MF, Patel HR, Mantilla RD, Velez JI, Schulte KM, Mastronardi C, Arcos-Burgos M, Anaya JM.

J Autoimmun. 2016 Aug;72:65-72. doi: 10.1016/j.jaut.2016.05.003. Epub 2016 May 18.

PMID:
27209085

Supplemental Content

Loading ...
Support Center